Insider Selling: Talasaz AmirAli, Guardant Health Inc [GH] Co-Chief Executive Officer divested 100,000 shares

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Guardant Health Inc shares valued at $5,087,630 were sold by Talasaz AmirAli on Jul 01 ’25. At $50.88 per share, Talasaz AmirAli sold 100,000 shares. The insider’s holdings dropped to 1,971,830 shares worth approximately $100.64 million following the completion of this transaction.

Also, Tariq Musa sold 3,213 shares, netting a total of over 158,947 in proceeds. Following the sale of shares at $49.47 each, the insider now holds 7,190 shares.

Before that, POTTER MYRTLE S had sold 26 shares from its account. In a trade valued at $1,286, the Director traded Guardant Health Inc shares for $49.47 each. Upon closing the transaction, the insider’s holdings decreased to 26 shares, worth approximately $0.93 million.

As published in their initiating research note from Mizuho on April 10, 2025, Guardant Health Inc [GH] has been an Outperform and the price target has been revised to $55. Analysts at Barclays started covering the stock with ‘”an Overweight”‘ outlook in a report released in late January. As of June 28, 2024, Guggenheim has increased its “Neutral” rating to a “Buy” for GH.

Analyzing GH Stock Performance

On last trading session,, Guardant Health Inc [NASDAQ: GH] rose 0.43% to $51.04. The stock’s lowest price that day was $50.15, but it reached a high of $51.9999 in the same session. During the last five days, there has been a surge of approximately 0.65%. Over the course of the year, Guardant Health Inc shares have jumped approximately 77.53%. Shares of the company reached a 52-week high of $53.42 on 06/27/25 and a 52-week low of $30.97 on 01/02/25.

Support And Resistance Levels for Guardant Health Inc (GH)

According to the 24-hour chart, there is a support level at 50.13, which, if violated, would cause prices to drop to 49.21. In the upper region, resistance lies at 51.98. The next price resistance is at 52.91. RSI (Relative Strength Index) is 61.04 on the 14-day chart, showing neutral technical sentiment.

Is Guardant Health Inc subject to short interest?

Stocks of Guardant Health Inc saw a sharp rise in short interest on 2025-06-13 jumping by 0.88 million shares to 10.0 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 9.12 million shares. A jump of 8.76% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 5.03 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.03.

Which companies own the most shares of Guardant Health Inc (GH)?

In terms of Guardant Health Inc share price expectations, FactSet research, analysts set an average price target of 61 in the next 12 months, up nearly 20.03% from the previous closing price of $50.82. Analysts anticipate Guardant Health Inc stock to reach 70 by 2025, with the lowest price target being 52. In spite of this, 13 analysts ranked Guardant Health Inc stock as Buy at the end of 2025. On April 24, 2024, Craig Hallum assigned a price target of “a Buy” to the stock and resumed coverage with a $28.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.